JAK Inhibitors Improve Vitiligo, Trials Show JAK Inhibitors Improve Vitiligo, Trials Show

Separate clinical trials of ruxolitinib and ritlecitinib showed both therapies resulted in significant repigmentation in patients with vitiligo.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Dermatology News Source Type: news